APA (7th ed.) Citation

Hanusch, C. A., Schneeweiss, A., Loibl, S., Untch, M., Paepke, S., Kümmel, S., . . . Minckwitz, G. v. (2016). Correction: Dual blockade with AFatinib and trastuzumab as NEoadjuvant treatment for patients with locally advanced or operable breast cancer receiving taxane-anthracycline containing chemotherapy-DAFNE (GBG-70). Clinical cancer research, 22(17), . https://doi.org/10.1158/1078-0432.CCR-16-1594

Chicago Style (17th ed.) Citation

Hanusch, Claus Alexander, et al. "Correction: Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy-DAFNE (GBG-70)." Clinical Cancer Research 22, no. 17 (2016). https://doi.org/10.1158/1078-0432.CCR-16-1594.

MLA (9th ed.) Citation

Hanusch, Claus Alexander, et al. "Correction: Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy-DAFNE (GBG-70)." Clinical Cancer Research, vol. 22, no. 17, 2016, https://doi.org/10.1158/1078-0432.CCR-16-1594.